{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:06:45Z","timestamp":1787969205480,"version":"build-2784847793"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01 AI030731"],"award-info":[{"award-number":["P01 AI030731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seattle Children\u2019s Research Institute Faculty Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Over the past several decades, there have been advances in diagnosis and treatment of neonatal herpes simplex virus (HSV) disease. There has been no recent comprehensive evaluation of the impact of these advances on the management and outcomes for neonates with HSV.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Clinical data for initial presentation, treatment, and outcomes were abstracted from medical records of neonates with HSV treated at Seattle Children\u2019s Hospital between 1980 and 2016.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred thirty infants with a diagnosis of neonatal HSV were identified. Between 1980 and 2016, high-dose acyclovir treatment for neonatal HSV infection increased from 0% to close to 95%, with subsequent decrease in overall HSV-related mortality from 20.9% to 5.6%. However, even among infants treated with high-dose acyclovir, mortality was 40.9% for infants with disseminated (DIS) disease, and only 55% of infants with central nervous system (CNS) disease were without obvious neurologic abnormalities at 24 months. Over the study period, the time between initial symptoms and diagnosis decreased. Skin recurrences were more common with HSV-2 than HSV-1 (80% vs 55%; P = .02) and in infants with lesions at initial diagnosis (76% vs 47%; P = .02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Changes in the standard of care for management of neonatal HSV disease have led to improvements in timeliness of diagnosis and outcome but mortality in infants with DIS disease and neurologic morbidity in infants with CNS disease remain high. Future research should focus on prevention of perinatal infection and subsequent recurrences.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpids\/piab105","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T17:22:30Z","timestamp":1634404950000},"page":"94-101","source":"Crossref","is-referenced-by-count":58,"title":["Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era"],"prefix":"10.1093","volume":"11","author":[{"given":"Ann J","family":"Melvin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Infectious Disease, University of Washington and Seattle Children\u2019s Research Institute, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Infectious Disease, University of Washington and Seattle Children\u2019s Research Institute, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi B","family":"Vora","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Infectious Disease, University of Washington and Seattle Children\u2019s Research Institute, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Selke","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Biostatistics Epidemiology and Analytics for Research Core, Seattle Children\u2019s Research Institute, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wald","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, Washington, USA"},{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"},{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"2022032516105815200_CIT0001","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2214-109X(16)30362-X","article-title":"First estimates of the global and regional incidence of neonatal herpes infection.","volume":"5","author":"Looker","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2022032516105815200_CIT0002","doi-asserted-by":"crossref","first-page":"e20152387","DOI":"10.1542\/peds.2015-2387","article-title":"Infant deaths due to herpes simplex virus, congenital syphilis, and HIV in New York City.","volume":"137","author":"Sampath","year":"2016","journal-title":"Pediatrics"},{"key":"2022032516105815200_CIT0003","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1542\/peds.108.2.230","article-title":"Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"key":"2022032516105815200_CIT0004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.108.2.223","article-title":"Natural history of neonatal herpes simplex virus infections in the acyclovir era.","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"key":"2022032516105815200_CIT0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJMoa1003509","article-title":"Oral acyclovir suppression and neurodevelopment after neonatal herpes.","volume":"365","author":"Kimberlin","year":"2011","journal-title":"N Engl J Med"},{"key":"2022032516105815200_CIT0006","volume-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2018","edition":"31st ed"},{"key":"2022032516105815200_CIT0007","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jpeds.2014.11.011","article-title":"Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.","volume":"166","author":"Melvin","year":"2015","journal-title":"J Pediatr"},{"key":"2022032516105815200_CIT0008","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jpeds.2012.04.009","article-title":"Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection.","volume":"161","author":"Cantey","year":"2012","journal-title":"J Pediatr"},{"key":"2022032516105815200_CIT0009","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/INF.0000000000002451","article-title":"Utility of surface and blood polymerase chain reaction assays in identifying infants with neonatal herpes simplex virus infection.","volume":"38","author":"Samies","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2022032516105815200_CIT0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.25.2.323-326.1987","article-title":"Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population.","volume":"25","author":"Lafferty","year":"1987","journal-title":"J Clin Microbiol"},{"key":"2022032516105815200_CIT0011","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/jcm.26.9.1772-1774.1988","article-title":"Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus.","volume":"26","author":"Langenberg","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2022032516105815200_CIT0012","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/JCM.40.7.2609-2611.2002","article-title":"Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.","volume":"40","author":"Jerome","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2022032516105815200_CIT0013","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1128\/JCM.01405-06","article-title":"Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa.","volume":"45","author":"Magaret","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2022032516105815200_CIT0014","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.20365","article-title":"Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time Taqman PCR assay.","volume":"76","author":"Corey","year":"2005","journal-title":"J Med Virol"},{"key":"2022032516105815200_CIT0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM199102143240704","article-title":"Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med"},{"key":"2022032516105815200_CIT0016","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/infdis\/174.6.1162","article-title":"Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.","volume":"174","author":"Kimberlin","year":"1996","journal-title":"J Infect Dis"},{"key":"2022032516105815200_CIT0017","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","article-title":"A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med"},{"key":"2022032516105815200_CIT0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(88)90997-X","article-title":"Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.","volume":"1","author":"Corey","year":"1988","journal-title":"Lancet"},{"key":"2022032516105815200_CIT0019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jpids\/pis068","article-title":"Primary maternal herpes simplex virus-1 gingivostomatitis during pregnancy and neonatal herpes: case series and literature review.","volume":"1","author":"Healy","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2022032516105815200_CIT0020"},{"key":"2022032516105815200_CIT0021","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/OLQ.0000000000001076","article-title":"Time trends in first-episode genital herpes simplex virus infections in an urban sexually transmitted disease clinic.","volume":"46","author":"Dabestani","year":"2019","journal-title":"Sex Transm Dis"},{"key":"2022032516105815200_CIT0022","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41372-019-0352-7","article-title":"Trends in the incidence, mortality, and cost of neonatal herpes simplex virus hospitalizations in the United States from 2003 to 2014.","volume":"39","author":"Donda","year":"2019","journal-title":"J Perinatol"},{"key":"2022032516105815200_CIT0023","doi-asserted-by":"crossref","first-page":"e20183233","DOI":"10.1542\/peds.2018-3233","article-title":"Neonatal herpes simplex virus infection among Medicaid-enrolled children: 2009-2015.","volume":"143","author":"Mahant","year":"2019","journal-title":"Pediatrics"},{"key":"2022032516105815200_CIT0024","doi-asserted-by":"crossref","first-page":"e00632","DOI":"10.1128\/JCM.00632-18","article-title":"Comparison of herpes simplex virus PCR with culture for virus detection in multisource surface swab specimens from neonates.","volume":"56","author":"Dominguez","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2022032516105815200_CIT0025","doi-asserted-by":"crossref","first-page":"F483","DOI":"10.1136\/fn.88.6.F483","article-title":"Relapse of neonatal herpes simplex virus infection.","volume":"88","author":"Kimura","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2022032516105815200_CIT0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jmv.10084","article-title":"Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2.","volume":"67","author":"Kimura","year":"2002","journal-title":"J Med Virol"},{"key":"2022032516105815200_CIT0027","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jiac.2015.08.005","article-title":"Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: case report.","volume":"21","author":"Kato","year":"2015","journal-title":"J Infect Chemother"},{"key":"2022032516105815200_CIT0028","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1093\/jpids\/pix017","article-title":"Delayed recurrence of herpes simplex virus infection in the central nervous system after neonatal infection and completion of six months of suppressive therapy.","volume":"6","author":"Henderson","year":"2017","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/11\/3\/94\/42994147\/piab105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/11\/3\/94\/42994147\/piab105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T20:55:06Z","timestamp":1648241706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/11\/3\/94\/6459765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,11]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,12,11]]},"published-print":{"date-parts":[[2022,3,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piab105","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,12,11]]}}}